Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit (Unaudited) - USD ($) |
Preferred Stock [Member]
Series A Redeemable Convertible Preferred Stock Without Giving Effect To The Reverse Stock Split [Member]
|
Preferred Stock [Member]
Series B Redeemable Convertible Preferred Stock Without Giving Effect To The Reverse Stock Split [Member]
|
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Total |
|---|---|---|---|---|---|---|
| Balance (in shares) at Dec. 31, 2016 | 56,321,165 | 51,069,262 | 19,548,969 | |||
| Balance at Dec. 31, 2016 | $ 12,734,000 | $ 15,897,000 | $ 20,000 | $ 118,000 | $ (19,733,000) | $ (19,595,000) |
| Stock-based compensation expense | 301,000 | 301,000 | ||||
| Exercise of warrants (in shares) | 351,493 | |||||
| Exercise of warrants | $ 80,000 | |||||
| Net loss | (11,561,000) | (11,561,000) | ||||
| Balance (in shares) at Dec. 31, 2017 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Dec. 31, 2017 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 438,000 | (31,294,000) | (30,855,000) |
| Stock-based compensation expense | $ 0 | $ 0 | $ 0 | 75,000 | 0 | 75,000 |
| Net loss | (1,523,000) | (1,523,000) | ||||
| Balance (in shares) at Mar. 31, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Mar. 31, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 513,000 | (32,817,000) | (32,303,000) |
| Balance (in shares) at Dec. 31, 2017 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Dec. 31, 2017 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 438,000 | (31,294,000) | (30,855,000) |
| Net loss | (4,451,000) | |||||
| Balance (in shares) at Sep. 30, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Sep. 30, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 663,000 | (35,744,000) | (35,080,000) |
| Balance (in shares) at Dec. 31, 2017 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Dec. 31, 2017 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 438,000 | (31,294,000) | (30,855,000) |
| Net loss | (5,985,000) | |||||
| Balance (in shares) at Dec. 31, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Dec. 31, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 747,000 | (37,279,000) | (36,531,000) |
| Balance (in shares) at Mar. 31, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Mar. 31, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 513,000 | (32,817,000) | (32,303,000) |
| Stock-based compensation expense | $ 0 | $ 0 | $ 0 | 75,000 | 0 | 75,000 |
| Net loss | (1,422,000) | (1,422,000) | ||||
| Balance (in shares) at Jun. 30, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Jun. 30, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 588,000 | (34,239,000) | (33,650,000) |
| Stock-based compensation expense | $ 0 | $ 0 | $ 0 | 75,000 | 0 | 75,000 |
| Net loss | (1,505,000) | (1,505,000) | ||||
| Balance (in shares) at Sep. 30, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Sep. 30, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 663,000 | (35,744,000) | (35,080,000) |
| Balance (in shares) at Dec. 31, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Dec. 31, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 747,000 | (37,279,000) | (36,531,000) |
| Stock-based compensation expense | 84,000 | 84,000 | ||||
| Net loss | $ 0 | $ 0 | $ 0 | 0 | (2,462,000) | (2,462,000) |
| Balance (in shares) at Mar. 31, 2019 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Mar. 31, 2019 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 831,000 | (39,741,000) | (38,909,000) |
| Balance (in shares) at Dec. 31, 2018 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Dec. 31, 2018 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 747,000 | (37,279,000) | (36,531,000) |
| Net loss | (9,033,000) | |||||
| Balance (in shares) at Sep. 30, 2019 | 5,807,877 | |||||
| Balance at Sep. 30, 2019 | $ 6,000 | 35,244,000 | (46,312,000) | (11,062,000) | ||
| Balance (in shares) at Mar. 31, 2019 | 2,034,548 | 1,833,387 | 701,808 | |||
| Balance at Mar. 31, 2019 | $ 12,814,000 | $ 15,897,000 | $ 1,000 | 831,000 | (39,741,000) | (38,909,000) |
| Stock-based compensation expense | 84,000 | 84,000 | ||||
| Conversion of convertible notes into convertible preferred stock (in shares) | 367,041 | |||||
| Conversion of convertible notes into convertible preferred stock | $ 3,203,000 | |||||
| Recognition of beneficial conversion feature upon conversion of convertible notes | $ 2,101,000 | |||||
| Conversion of of convertible preferred stock into common stock (in shares) | (2,034,548) | (2,200,428) | 4,234,976 | |||
| Conversion of of convertible preferred stock into common stock | $ (12,814,000) | $ (21,201,000) | $ 4,000 | 34,011,000 | 34,015,000 | |
| Issuance of common stock for merger (in shares) | 854,017 | |||||
| Issuance of common stock for merger | $ 1,000 | 5,246,000 | 5,247,000 | |||
| Equity issuance costs paid in stock (in shares) | 17,076 | |||||
| Exercise of warrants | 234,000 | 234,000 | ||||
| Dividend | (5,245,000) | (5,245,000) | ||||
| Spin-off of AquaMed | (1,000) | (1,000) | ||||
| Net loss | 0 | 0 | $ 0 | 0 | (4,676,000) | (4,676,000) |
| Balance (in shares) at Jun. 30, 2019 | 5,807,877 | |||||
| Balance at Jun. 30, 2019 | $ 6,000 | 35,160,000 | (44,417,000) | (9,251,000) | ||
| Stock-based compensation expense | 84,000 | 84,000 | ||||
| Net loss | $ 0 | $ 0 | $ 0 | 0 | (1,895,000) | (1,895,000) |
| Balance (in shares) at Sep. 30, 2019 | 5,807,877 | |||||
| Balance at Sep. 30, 2019 | $ 6,000 | $ 35,244,000 | $ (46,312,000) | $ (11,062,000) |